Inspiration, Ipsen Try to Lock Up Hemophilia Market in $259M Deal

Jan 22, 2010 | Posted by: roboblogger | Full story: BioWorld

Inspiration Pharmaceuticals Inc. and Ipsen SA are merging their hemophilia portfolios in a deal that will see Ipsen invest $259 million to fund clinical development of the two lead products, while Inspiration handles the work.

Comments

Showing posts 1 - 2 of2
tiffany holland

Huntersville, NC

|
Report Abuse
|
Judge it!
|
#1
Jan 22, 2010
 
this is amazing! i have a 19 month old with hemophila A and it really is a blessing to have others that work so hard to find medications that will help my son live a happy long life!!
D MARTIN

Redhill, UK

|
Report Abuse
|
Judge it!
|
#2
Jun 29, 2012
 
I Hear that the INSPIRATION FIX product trial has been stopped by the FDA

Tell me when this thread is updated: (Registration is not required)

Add to my Tracker Send me an email

Showing posts 1 - 2 of2
Type in your comments below
Name
(appears on your post)
Comments
Characters left: 4000
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

•••
•••
•••
•••

Camp Pendleton Jobs

•••
•••
•••

Camp Pendleton People Search

Addresses and phone numbers for FREE

•••

Personal Finance

Mortgages [ See current mortgage rates ]
•••